• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CFO Glaser Shelagh exercised 7,310 shares at a strike of $349.96 and sold $3,550,609 worth of shares (7,310 units at $485.72) (SEC Form 4)

    6/9/25 1:17:16 PM ET
    $SNPS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SNPS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Glaser Shelagh

    (Last) (First) (Middle)
    675 ALMANOR AVENUE

    (Street)
    SUNNYVALE CA 94085

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    SYNOPSYS INC [ SNPS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    CFO
    3. Date of Earliest Transaction (Month/Day/Year)
    06/06/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/06/2025 M 2,086 A $354.45 17,377 D
    Common Stock 06/06/2025 S 2,086 D $485.7194(1) 15,291 D
    Common Stock 06/06/2025 M 5,224 A $348.17 20,515 D
    Common Stock 06/06/2025 S 5,224 D $485.7194(1) 15,291 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Non-Qualified Stock Option (right to buy) $348.17 06/06/2025 M(2) 5,224 12/02/2023(3) 12/02/2029 Common Stock 5,224 $0.0 15,673 D
    Non-Qualified Stock Option (right to buy) $354.45 06/06/2025 M(2) 2,086 02/17/2024(3) 02/17/2030 Common Stock 2,086 $0.0 7,452 D
    Explanation of Responses:
    1. Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $483.38 to $487.95. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
    2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted January 13, 2025.
    3. 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
    By: POA pursuant Liz Ramirez For: Shelagh Glaser 06/09/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SNPS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNPS

    DatePrice TargetRatingAnalyst
    1/13/2025$600.00Buy
    Redburn Atlantic
    11/22/2024$570.00Equal Weight
    Wells Fargo
    11/12/2024$675.00Buy
    Loop Capital
    10/22/2024$650.00Outperform
    Mizuho
    10/15/2024$660.00Buy
    Berenberg
    4/4/2024$665.00Overweight
    Piper Sandler
    11/30/2023$500.00 → $660.00Buy
    Needham
    11/10/2023$600.00Overweight
    Morgan Stanley
    More analyst ratings